Michael Rapé
Consultant / Advisor at MONTE ROSA THERAPEUTICS, INC.
Profile
Michael Rapé is the founder of Nurix Therapeutics, Inc. (founded in 2009) and Lyterian Therapeutics, Inc. (founded in 2022).
He is currently the Head & Division of Molecular Therapeutics at the University of California, Berkeley since 2022.
He is also an iPartner at The Column Group LLC since 2021, a Scientific Advisor at Monte Rosa Therapeutics, Inc. since 2020, and a Scientific Advisor at Berkeley Frontier Fund.
Additionally, he is a Member & Scientific Advisory Board at Vicinitas Therapeutics since 2022.
Dr. Rapé obtained his doctorate degree from the Max Planck Institute of Biochemistry in 2002.
Michael Rapé active positions
| Companies | Position | Start |
|---|---|---|
| MONTE ROSA THERAPEUTICS, INC. | Consultant / Advisor | 01/09/2020 |
Berkeley Frontier Fund
 Berkeley Frontier Fund Investment ManagersFinance Berkeley Frontier Fund (Berkeley Frontier Fund) is a venture capital firm founded in 202. The firm is headquartered in Berkeley, California. | Consultant / Advisor | - |
The Column Group LLC
 The Column Group LLC Investment ManagersFinance The Column Group LLC is a venture capital firm founded in 2005 by Peter Svennilson. The firm is headquartered in San Francisco. | Private Equity Investor | 01/01/2021 |
Vicinitas Therapeutics
 Vicinitas Therapeutics BiotechnologyHealth Technology Vicinitas Therapeutics is located in the US. Vicinitas Therapeutics is an American US-based biotechnology company that specializes in developing next-generation disease therapies using targeted protein stabilizers called Deubiquituinase Targeting Chimeras (DUBtacs). The company's mission is to solve critical problems in human health by developing disease therapies against an entire class of previously inaccessible disease-causing proteins. | Consultant / Advisor | 01/07/2022 |
| University of California, Berkeley | Corporate Officer/Principal | 01/07/2022 |
Former positions of Michael Rapé
| Companies | Position | End |
|---|---|---|
| NURIX THERAPEUTICS, INC. | Founder | - |
Training of Michael Rapé
| Max Planck Institute of Biochemistry | Doctorate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 2 |
|---|---|
| NURIX THERAPEUTICS, INC. | Health Technology |
| MONTE ROSA THERAPEUTICS, INC. | Health Technology |
| Private companies | 3 |
|---|---|
The Column Group LLC
The Column Group LLC Investment ManagersFinance The Column Group LLC is a venture capital firm founded in 2005 by Peter Svennilson. The firm is headquartered in San Francisco. | Finance |
Berkeley Frontier Fund
Berkeley Frontier Fund Investment ManagersFinance Berkeley Frontier Fund (Berkeley Frontier Fund) is a venture capital firm founded in 202. The firm is headquartered in Berkeley, California. | Finance |
Vicinitas Therapeutics
Vicinitas Therapeutics BiotechnologyHealth Technology Vicinitas Therapeutics is located in the US. Vicinitas Therapeutics is an American US-based biotechnology company that specializes in developing next-generation disease therapies using targeted protein stabilizers called Deubiquituinase Targeting Chimeras (DUBtacs). The company's mission is to solve critical problems in human health by developing disease therapies against an entire class of previously inaccessible disease-causing proteins. | Health Technology |
- Stock Market
- Insiders
- Michael Rapé
